Showing results (81-90 of 468) with videos related to

Sort By:
Pageof 47
Urologic Oncology|February 4, 2018
Organizing a clinical trial for the new investigatorJanet Baack Kukreja, Ian M Thompson, Brian F Chapin
ISRN Oncology|April 24, 2012
High-grade prostate cancer: favorable results in the modern era regardless of initial treatmentEmma H Ramahi, Gregory P Swanson, Matthew W Jackson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2018
Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921Maha Hussain, Catherine M Tangen, Ian M Thompson, et al.
American Journal of Clinical Pathology|October 20, 2020
Gleason Score Evolution and the Effect on Prostate Cancer OutcomesGregory P Swanson, Sean Trevathan, Kendall A P Hammonds, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2012
Limited PSA testing in indigent men in South Texas: an appropriate care or missing a prevention opportunity?Yuanyuan Liang, Fei Du, Ian M Thompson, et al.
Clinical and Translational Radiation Oncology|July 11, 2022
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvisGarrett L Jensen, Sameer G Jhavar, Chul S Ha, et al.
Bladder (San Francisco, Calif.)|August 11, 2020
Outcomes of patients undergoing radiation therapy for bladder cancerSalman Hasan, Eva Mercedes Galvan, Courtney Shaver, et al.
Current Oncology Reports|April 7, 2004
What's new in the field of prostate cancer chemoprevention?Kanwaljit Mahal, Javier Hernandez, Joseph W Basler, et al.
Current Urology Reports|May 5, 2005
What's new in the field of prostate cancer chemoprevention?Kanwaljit Mahal, Javier Hernandez, Joseph W Basler, et al.
The Journal of Urology|February 1, 2015
Active Surveillance is an Appropriate Management Strategy for a Proportion of Men Diagnosed with Prostate Cancer by Prostate Specific Antigen TestingStephen Overholser, Matthew Nielsen, Kathleen Torkko, et al.
Pageof 47